• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconJohnson & Johnson

Johnson & Johnson

Page 3 of 18
a person uses Johnson & Johnson baby powder.
Finance
Johnson & Johnson offers $8.9 billion settlement to roughly 60,000 people who claim its talc products gave them cancer
By Jef Feeley, Steven Church and BloombergApril 5, 2023
Impella patient
Health
Johnson & Johnson is paying $17.3 billion to buy a company that helps your heart pump blood
By Madison Muller and BloombergNovember 1, 2022
Chief diversity officers on the key to leveling the corporate playing field
Conferences
Chief diversity officers on the key to leveling the corporate playing field
By Kristine GillSeptember 16, 2022
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By Paige McGlauflinAugust 15, 2022
Johnson baby powder is displayed on a table.
Health
Johnson & Johnson to stop selling talc-based baby powder as cancer lawsuits pile on
By Riley Griffin, Jef Feeley and BloombergAugust 11, 2022
Alex Gorsky, chief executive officer of Johnson & Johnson, speaks during an event in the Eisenhower Executive Office Building in Washington, D.C., U.S., on Wednesday, March 10, 2021.
Newsletters
The wisdom of J&J’s Alex Gorsky
By David Meyer and Alan MurrayJune 10, 2022
Musk claims S&P ‘lost their integrity’ after Tesla gets booted from sustainability index while Exxon is included
Finance
Musk claims S&P ‘lost their integrity’ after Tesla gets booted from sustainability index while Exxon is included
By Christiaan HetznerMay 18, 2022
A nurse prepares a pediatric dose of the Pfizer-BioNTech Covid-19 vaccine.
Health
FDA restricts Johnson & Johnson’s COVID-19 vaccine to people 18 and older due to blood clot risk
By Matthew Perrone, Lauran Neergaard and The Associated PressMay 5, 2022
Albert Bourla, chairman and chief executive officer of Pfizer Inc., speaks during South By Southwest.
Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By Sy Mukherjee and IDEA PharmaApril 20, 2022
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
Health
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By Andrew MarquardtMarch 15, 2022
a man and a woman looking at an iPhone in a store
Leadership
Apple, Walt Disney, and UnitedHealth have this in common: Their business rivals give them ultra-high performance scores
By Matthew Heimer and Scott DeCarloFebruary 2, 2022
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
Health
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
By Erika Fry and Nicolas RappJanuary 5, 2022
A Johnson & Johnson booster reduces Omicron hospitalizations by up to 85%, says a new South African study
Health
A Johnson & Johnson booster reduces Omicron hospitalizations by up to 85%, says a new South African study
By Michelle Fay Cortez and BloombergDecember 30, 2021
A health care worker prepares a Moderna booster vaccine dose.
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By David MeyerDecember 27, 2021
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By BloombergDecember 17, 2021
1
  • 1
  • 2
  • 3
  • 4
  • 5
...18
Most Popular
Economy
How Scott Bessent used financial engineering to finance the $2 trillion deficit while leaving it untouched—and created a $1.45 trillion shortfallplaceholder alt text
By Eva RoytburgAugust 8, 2026
Real Estate
Meet the 33-year-old CEO betting on boomers chasing their grandkids—and millennials selling their first houseplaceholder alt text
By Nick LichtenbergAugust 8, 2026
Real Estate
The tables have turned: Florida and Texas are the biggest losers in the housing market as Ohio emerges a surprise winnerplaceholder alt text
By Sydney LakeAugust 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.